| Literature DB >> 33572224 |
Roberta Dal Magro1, Agostina Vitali2, Stefano Fagioli1, Alberto Casu3, Andrea Falqui3, Beatrice Formicola1, Lorenzo Taiarol1, Valeria Cassina1, Claudia Adriana Marrano1, Francesco Mantegazza1, Umberto Anselmi-Tamburini2, Patrizia Sommi4, Francesca Re1.
Abstract
Vascular oxidative stress is considered a worsening factor in the progression of Alzheimer's disease (AD). Increased reactive oxygen species (ROS) levels promote the accumulation of amyloid-β peptide (Aβ), one of the main hallmarks of AD. In turn, Aβ is a potent inducer of oxidative stress. In early stages of AD, the concomitant action of oxidative stress and Aβ on brain capillary endothelial cells was observed to compromise the blood-brain barrier functionality. In this context, antioxidant compounds might provide therapeutic benefits. To this aim, we investigated the antioxidant activity of cerium oxide nanoparticles (CNP) in human cerebral microvascular endothelial cells (hCMEC/D3) exposed to Aβ oligomers. Treatment with CNP (13.9 ± 0.7 nm in diameter) restored basal ROS levels in hCMEC/D3 cells, both after acute or prolonged exposure to Aβ. Moreover, we found that the extent of CNP uptake by hCMEC/D3 was +43% higher in the presence of Aβ. Scanning electron microscopy and western blot analysis suggested that changes in microvilli structures on the cell surface, under pro-oxidant stimuli (Aβ or H2O2), might be involved in the enhancement of CNP uptake. This finding opens the possibility to exploit the modulation of endothelial microvilli pattern to improve the uptake of anti-oxidant particles designed to counteract ROS-mediated cerebrovascular dysfunctions.Entities:
Keywords: amyloid-beta; blood-brain barrier; cerium oxide nanoparticles; endothelial cells; microvilli
Year: 2021 PMID: 33572224 PMCID: PMC7916071 DOI: 10.3390/antiox10020266
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921